New radiation dose may tame eye cancer with fewer side effects

NCT ID NCT07210749

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a lower dose of radiation (12 Gy in 6 sessions) for people with low-grade B-cell orbital lymphoma, a slow-growing eye cancer. The goal is to see if this dose can control the tumor as well as the standard higher dose (24-25 Gy) while causing fewer long-term side effects. About 36 adults with this condition will take part. If successful, this approach could offer a gentler treatment option.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ORBITAL LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • BC Cancer Vancouver

    Vancouver, British Columbia, V5Z4E6, Canada